Global Experts Discuss Current and Emerging Treatments for ET and PV

In this podcast episode, Ciro Rinaldi MD, PhD, and Alessandro M. Vannucchi, MD, discuss contemporary management of essential thrombocythemia (ET) and polycythemia vera (PV), as well as novel investigational approaches, including the following:

Overview of current treatment paradigms for PV and ET Importance of shared decision-making and patient communication in determining treatment Current therapeutic areas of need in ET and PV Emerging investigational therapeutics

Presenters:
Ciro Rinaldi MD, PhD
Chief Medical Officer, United Lincolnshire Teaching Hospital
Honorary Professor of Haematology, University of Lincoln
Honorary Professor De Montfort University Dubai
Consultant Haematologist
Lincoln, United Kingdom

Alessandro M. Vannucchi, MD
Professor of Hematology
University of Florence
Director of Hematology Department
Director of Oncology Department
Azienda Ospedaliera Universitaria Careggi
Florence, Italy

Content based on an online CME program supported by an educational grant from Merck.

Link to full program:
https://bit.ly/4u09lKd

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.